A High-Risk Antiphospholipid Antibody Profile Matters in Pediatric Patients with Antiphospholipid Syndrome
SAN DIEGO, Nov. 12, 2023 /PRNewswire/ — A new study by Hospital for Special Surgery (HSS) investigators has found that…
Brand Post
HELUNA HEALTH LAUNCHES COPI–A DATA-DRIVEN MEASURE OF LOCAL RESILIENCE AND OUTBREAK PREPAREDNESS
LOS ANGELES, Nov. 12, 2023 /PRNewswire/ — Population health leader Heluna Health has launched the first research tool enabling California officials and…
HELUNA HEALTH DATA BRIEF: HIGH HOUSING COSTS AND LOW QUALITY SIGNIFICANTLY REDUCE OUTBREAK PREPAREDNESS — IN MOST CALIFORNIA COUNTIES, OVER 15% OF RESIDENTS SPEND AT LEAST HALF OF THEIR INCOME ON HOUSING
LOS ANGELES, Nov. 12, 2023 /PRNewswire/ — Population health leader Heluna Health has released a new data brief showing alignment between the…
Michael Happe of Winnebago Industries named Entrepreneur Of The Year® 2023 National Overall Award Winner
PALM SPRINGS, Calif., Nov. 12, 2023 /PRNewswire/ — Ernst & Young LLP (EY US) today announced that Michael Happe, President…
ADCOLOR Announces Winners of the 17th Annual ADCOLOR Awards
Presented by Disney, Google | YouTube and Spotify LOS ANGELES, Nov. 12, 2023 /PRNewswire/ — ADCOLOR, the premier organization dedicated…
ROSEN, NATIONAL TRIAL LAWYERS, Encourages DocGo Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – DCGO
NEW YORK, Nov. 11, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities…
ROSEN, TRIAL ATTORNEYS, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SCYX
NEW YORK, Nov. 11, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of…
OKX Executives Champion Crypto, Web3 Adoption and Trust at LABITCONF
OKX President Hong Fang spoke on: “The Path to Security & Trust: How OKX is Advancing Crypto Industry Standards” OKX…
Ionis shares positive clinical update from ongoing trial of ION582 for Angelman syndrome
Part 1 of HALOS trial evaluating ION582 has completed enrollment with results expected in mid-2024 ION582 has been generally well…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Airbnb, Inc. – ABNB
NEW YORK, Nov. 11, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Airbnb, Inc. (“Airbnb”…
↑